Your browser doesn't support javascript.
loading
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
Décary, Simon; de Wit, Maarten; Naye, Florian; Barton, Jennifer L; Fraenkel, Liana; Li, Linda C; Brooks, Peter; Stacey, Dawn; Maxwell, Lara J; Campbell, Willemina; Hofstetter, Cathie; Voshaar, Marieke; Meara, Alexa; Christensen, Robin; Boonen, Annelies; Suarez-Almazor, Maria E; Meade, Tanya; March, Lyn; Jull, Janet Elizabeth; Alten, Rieke; Morgan, Esi M; Stewart Hazlewood, Glen; Barber, Claire E H; Guillemin, Francis; El-Miedany, Yasser; Mittoo, Shikha; Robertson, Tiffany Westrich; Bartlett, Susan J; Singh, Jasvinder A; Mannion, Melissa; Nasef, Samah Ismail; Boel, Anne; Adebajo, Adewale; Arnaud, Laurent; Gill, Tiffany K; Moholt, Ellen; Burt, Jennifer; Jayatilleke, Arundathi; Hmamouchi, Ihsane; Berthelsen, Dorthe B; Blanco, Francisco J; Mather, Kate; Maharaj, Ajesh; Sharma, Saurab; Caso, Francesco; Beaton, Dorcas; Shea, Beverly; Fong, Christopher; Fernandez, Anthony P; Mackie, Sarah.
Affiliation
  • Décary S; Faculty of Medicine and Health Sciences, School of Rehabilitation, Research Centre of the CHUS, CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, Canada.
  • de Wit M; Patient Research Partner, Amsterdam, The Netherlands.
  • Naye F; Faculty of Medicine and Health Sciences, School of Rehabilitation, Research Centre of the CHUS, CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, Canada.
  • Barton JL; VA Portland Health Care System, Oregon Health & Science University, Portland, USA.
  • Fraenkel L; Department of Internal Medicine, Yale University, New Haven, USA.
  • Li LC; Department of Physical Therapy, University of British Columbia; Arthritis Research Canada, Canada.
  • Brooks P; School of Population and Global Health, University of Melbourne and Northern Health, Melbourne, Australia.
  • Stacey D; School of Nursing, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Canada.
  • Maxwell LJ; Centre for Practice Changing Research, Ottawa Hospital Research Institute and Faculty of Medicine, University of Ottawa, Ottawa, Canada.
  • Campbell W; Patient Research Partner, Toronto Western Hospital, University Health Network, Canada.
  • Hofstetter C; Patient Research Partner, Canada.
  • Voshaar M; Patient Research Partner; Department of Pharmacy and Department of Research & Innovation, Sint Maartenskliniek, Nijmegen, The Netherlands; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands.
  • Meara A; Division of Rheumatology, The Ohio State University, Columbus, USA.
  • Christensen R; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, & Department of Rheumatology, Odense University Hospital, Odense, Denmark.
  • Boonen A; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, Maastricht, The Netherlands.
  • Suarez-Almazor ME; Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Meade T; Western Sydney University, Sydney, Australia.
  • March L; Department of Rheumatology, Royal North Shore Hospital; The University of Sydney, Australia.
  • Jull JE; School of Rehabilitation Therapy, Queen's University, Kingston, Canada.
  • Alten R; Department of Internal Medicine II, Rheumatology Research Center, Rheumatology, Clinical Immunology, Osteology, Physical Therapy and Sports Medicine, Schlosspark-Klinik, Charité, University Medicine Berlin, Berlin, Germany.
  • Morgan EM; Department of Pediatrics, University of Washington. Division of Rheumatology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Stewart Hazlewood G; Department of Medicine, University of Calgary, Calgary, Canada.
  • Barber CEH; Department of Medicine, Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Guillemin F; INSPIIRE, Université de Lorraine, Inserm, Nancy, France.
  • El-Miedany Y; Canterbury Christ Church University, Canterbury; King's College London, London, United Kingdom.
  • Mittoo S; Vanshavardhana Canada Integrated Health, Toronto, Canada.
  • Robertson TW; CEO, Patient research partner, International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis), USA.
  • Bartlett SJ; Divisions of Clinical Epidemiology, Rheumatology and Respiratory Epidemiology and Clinical Trials Unit, McGill University; Research Institute, McGill University Health Centre; Johns Hopkins Medicine Division of Rheumatology, Montreal, Canada.
  • Singh JA; University of Alabama at Birmingham, Birmingham, USA.
  • Mannion M; Department of Pediatrics, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Nasef SI; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  • Boel A; Department of Rheumatology, Leiden University Medical Centre; UCB Pharma, B.V. Netherlands, Leiden, the Netherlands.
  • Adebajo A; Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom.
  • Arnaud L; Department of Rheumatology, CRMR RESO, University Hospitals of Strasbourg, Strasbourg, France.
  • Gill TK; Faculty of Health and Medical Sciences, Adelaide Medical School, The University of Adelaide, Australia.
  • Moholt E; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Norway.
  • Burt J; Newfoundland and Labrador Health Services, St. Clare's Mercy Hospital, St John's, Newfoundland and Labrador, Canada.
  • Jayatilleke A; Lewis Katz School of Medicine, Temple University, USA.
  • Hmamouchi I; Health Sciences Research Centre (CReSS), Faculty of Medicine, International University of Rabat (UIR), Rabat, Morocco.
  • Berthelsen DB; Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense; Department of Rehabilitation, Municipali
  • Blanco FJ; Departamento de Fisioterapia, Medicina y Ciencias Médicas, Universidad de A Coruña, A Coruña, Spain, Spain.
  • Mather K; Patient Research Partner, Toronto, Canada.
  • Maharaj A; Department of Internal Medicine, University of KwaZulu Natal, Durban, South Africa.
  • Sharma S; School of Health Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; Centre for Pain IMPACT, Neuroscience Research Australia, Sydney, Australia.
  • Caso F; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Beaton D; Institute for Work & Health, Toronto, Canada.
  • Shea B; Bruyère Research Institute; Ottawa Hospital Research Institute; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada.
  • Fong C; Eastern Clinical Research Unit, Monash University, Melbourne, Australia.
  • Fernandez AP; Departments of Dermatology and Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Mackie S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, University of Leeds, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Semin Arthritis Rheum ; 65: 152381, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38306813
ABSTRACT

OBJECTIVE:

To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions.

METHODS:

Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains.

RESULTS:

WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains.

CONCLUSION:

Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set. CLINICAL

SIGNIFICANCE:

The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology Type of study: Prognostic_studies Limits: Humans Language: En Journal: Semin Arthritis Rheum Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology Type of study: Prognostic_studies Limits: Humans Language: En Journal: Semin Arthritis Rheum Year: 2024 Document type: Article